Skip to main content
Skip to footer content
Disable Carousel Autoplay
Sign In
Account
Sign In
Create Account
Forgot Password
Cart
({{ totalItems }})
{{ totalItems }} items
Cart
Close Cart
Your cart is empty
{{ item.productName }}
{{ FormatPrice(item.productTotalPrice) }}
Format: {{ item.productVariantType }}
QTY:
{{ item.productQuantity }}
Checkout ({{ totalItems }})
Shop
Standards
Packages
Subscription Products
Education
Featured Products
CLSI M100
Performance Standards for Antimicrobial Susceptibility Testing
35th Edition
Microbiology
$180.00
Log in
view your exclusive member pricing.
CLSI EP07
Interference Testing in Clinical Chemistry
Third Edition
Method Evaluation
$180.00
Log in
view your exclusive member pricing.
Membership
Organizations
Individuals
Meet our Members
Participate
Standards Development
Specialty Areas
Standards Implementation
Resources
About
History & Impact
Leadership
Partners
Excellence Awards
News
Contact
Shop
Shop Page
Standards
Packages
Subscription Products
Education
Membership
Membership Page
Organizations
Individuals
Meet our Members
Participate
Standards Development
Standards Development Page
Specialty Areas
Standards Implementation
Resources
About
About Page
History & Impact
Leadership
Partners
Excellence Awards
News
Contact
Account
Sign In
Create Account
Forgot Password
Home
Resources
Insights
Robert Bowden
Robert Bowden
Beth Israel Deaconess Medical Center, Boston, MA Andrea Ferrell, BD Life Sciences, Sparks, MD
Posts Authored By Robert Bowden
Changes in Methodology and Breakpoints for Staphylococcus spp. Linezolid and Tedizolid Disk Diffusion Tests
Tedizolid disk diffusion breakpoints for staphylococci, beta-hemolytic streptococci and viridans streptococci were added to CLSIM100 in 2024.
Robert Bowden
May 1, 2025
See More Blog Posts